Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial.
Giles JT, Rist PM, Liao KP, Tawakol A, Fayad ZA, Mani V, Paynter NP, Ridker PM, Glynn RJ, Lu F, Broderick R, Murray M, Vanni KMM, Solomon DH, Bathon JM.
Giles JT, et al. Among authors: glynn rj.
ACR Open Rheumatol. 2021 Jun;3(6):371-380. doi: 10.1002/acr2.11256. Epub 2021 May 1.
ACR Open Rheumatol. 2021.
PMID: 33932148
Free PMC article.
Review.